Host: Bruce Japsen
Guest: Jeffrey Aronin, MBA
At a time drug companies are looking for new answers when it comes to developing new products and having a difficult time, the pharmaceutical industry may be on the verge of a different tact: turning to physcians and their advocacy organizations. Jeffrey Aronin, president and CEO of Ovation Pharmaceuticals Inc. tells the Chicago Tribune's Bruce Japsen about how his company has been getting some of its best ideas for drug development from doctors practicing in the field.
